This transcript is for your personal, non-commercial usage only. To bid presentation-ready copies for organisation to your colleagues, clients oregon customers sojourn http://www.djreprints.com.
https://www.barrons.com/articles/merck-acceleron-pharma-report-51632823521
Updated Sept. 28, 2021 8:25 americium ET / Original Sept. 28, 2021 6:05 americium ET
- Order Reprints
- Print Article
U.S. pharmaceutical radical Merck is successful precocious talks to get Acceleron Pharma, a determination that would adhd drugs to dainty uncommon diseases to Merck’s existent pipeline.
The statement could beryllium finalized arsenic soon arsenic this week, The Wall Street Journal reported, citing radical acquainted with the move. The woody would worth Acceleron astatine astir $11 billion, oregon astir $180 a share, and would beryllium 1 of Merck’s biggest acquisitions.
Merck...
/etf_analysis_proshares_ultrapro_nasdaq_biotech__ss-5bfc3af846e0fb0051c1e7d5.jpg)
English (US) ·